Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Dose-Escalation Study of the Safety and Tolerability of INCB050465 in Participants With Pemphigus Vulgaris

NCT03780166 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03780166
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03780166 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Dose-Escalation Study of the Safety and Tolerability of INCB050465 in Participants With Pemphigus Vulgaris
Lead sponsor
Incyte Corporation
Phase
Phase 2
Overall status
Withdrawn
Start date
March 31, 2019
Completion date
November 30, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pemphigus vulgaris